Table 5 Multivariate model of the association between subclinical atherosclerosis with sociodemographic variables, habits, family history, clinical parameters, lipid profile, fasting glucose and features related to HIV by age group including all patients (total of 694 patients)

Age (continuous)

1.12 (1.05 – 1.20)

0.001

1.11 (1.05 – 1.17)

< 0.001

Male sex

2.77 (1.43 – 5.34)

0.002

1.62 (0.94 – 2.81)

0.080

Nonwhite

3.01 (1.23 - 6.53)

0.007

1.37 (0.73 – 2.57)

0.321

BMI overweight

1.65 (0.79 – 3.44)

0.344

1.93 (1.04 – 3.57)

0.036

Obese

5.13 (1.79 – 14.7)

0.002

2.53 (0.85 – 7.54)

0.095

Metabolic Syndrome

3.30 (1.44 – 7.58)

0.005

1.01 (0.54 – 1.88)

0.968

Total cholesterol <200

1.0

1.0

200 to < 240 mg/dL

0.83 (0.32 - 2.03)

0.701

1.24 (0.66 – 2.32)

0.491

≥ 240 mg/dL

2.28 (0.83 – 9.40)

0.095

2.14 (0.76 – 5.98)

0.145

Stable partner

2.07 (1.03 – 4.19)

0.041

2.41 (1.24 – 4.67)

0.009

CD4+ T-lymphocytes <200

1.0

1.0

200 to < 350 cels/mm³

0.86 (0.33 – 2.24)

0.758

1.18 (0.59 – 2.37)

0.631

≥ 350 cels/mm³

0.71 (0.24 – 2.09)

0.542

2.81 (1.22 – 6.47)

0.015

HAART duration of use

No HAART use

1.0

1.0

PI < 5 years

0.64 (0.27 – 1.54)

0.323

0.67 (0.32 – 1.39)

0.287

PI ≥ 5 years

2.15 (0.23 – 20.1)

0.503

1.81 (0.38 – 8.59)

0.453

NNRTI < 5 years

1.52 (0.74 – 3.08)

0.248

1.31 (0.66 – 2.60)

0.426

NNRTI ≥ 5 years

1.94 (0.62 – 6.07)

0.254

2.65 (1.10 – 6.37)

0.028